cytogenetic

Related by string. cytogenetics * * additional cytogenetic abnormalities . deletion 5q cytogenetic abnormality . include cytogenetics fluorescence . unfavorable cytogenetics . cytogenetic response . complete cytogenetic . cytogenetic responses . cytogenetic abnormalities . cytogenetic analyzes . based cytogenetic diagnostics . complete cytogenetic response *

Related by context. All words. (Click for frequent words.) 66 aCGH 66 array CGH 65 gene expression profiling 64 comparative genomic hybridization 64 cytogenetics 64 gene expression profiles 64 genomic 63 miRNA expression 63 genomewide 63 microarray analysis 63 HLA typing 62 immunohistochemical 62 microRNA expression 61 somatic mutations 61 single nucleotide polymorphism 61 karyotyping 61 chromatin immunoprecipitation ChIP 61 SNP genotyping 61 quantitative gene expression 61 microarray experiments 60 miRNA profiling 60 gene expression assays 60 genomic profiling 60 genotyping 60 #S rDNA 60 molecular profiling 60 immunohistochemistry IHC 60 KRAS mutation 60 ChIP chip 60 histologic 60 genotypic 60 formalin fixed paraffin embedded 59 genomic alterations 59 proteomic 59 predictive biomarker 59 multiplex PCR 59 molecular biomarker 59 TMPRSS2 ERG 59 bisulfite sequencing 59 tumor biopsies 59 p# biomarker 59 transcriptome sequencing 59 histopathologic 59 NPM1 59 histopathological 59 microdeletions 59 microarray 59 pharmacogenetic testing 59 #S rRNA gene 58 FFPE 58 abnormal cytology 58 genomic proteomic 58 SNP arrays 58 gene expression patterns 58 HybSelect 58 K ras mutations 58 toxicogenomic 58 MammaPrint R 58 exome sequencing 58 transcriptomic 58 clinicopathological 58 miRNA 58 KRAS mutations 58 exome 58 ChIP Seq 58 MLH1 58 IL#B 58 massively parallel sequencing 58 quantitative PCR 58 mitochondrial DNA mtDNA 58 morphologic 57 transcriptomes 57 prognostic markers 57 phylogenetic analyzes 57 phenotyping 57 qRT PCR 57 situ hybridization 57 quantitative RT PCR 57 Sanger sequencing 57 gene amplification 57 pancreatic adenocarcinoma 57 biomarker discovery validation 57 papillary renal cell carcinoma 57 haematological 57 immunochemical fecal occult 57 microRNA biomarkers 57 molecular pathology 57 allelic 57 #p# [001] 57 PARP inhibition 57 sDNA 57 nested PCR 57 chromatin immunoprecipitation 57 breast carcinomas 57 transcriptome analysis 57 PITX2 57 #q#.# [001] 57 Recurrence Score 57 tissue microarrays 57 multigene 57 immunohistochemical staining 57 methylation markers 57 Cytogenetic 57 genotyping assays 57 nucleic acid isolation 57 EGFR mutations 57 number variation CNV 56 5 hmC 56 RT qPCR 56 DNA methylation 56 pharmacogenetic 56 molecular cytogenetic 56 ERBB2 56 CNVs 56 biomarker validation 56 splice variants 56 serologic 56 biomarker assays 56 autosomal 56 K ras 56 mtDNA 56 quantitative PCR qPCR 56 biomarker 56 ZNF# 56 gefitinib Iressa 56 hierarchical clustering 56 epithelial tumors 56 PIK3CA 56 preoperative staging 56 JAK2 V#F 56 immunochemical 56 gene loci 56 autism susceptibility genes 56 Western blotting 56 microarray gene expression 56 immunohistochemistry 56 clinicopathological features 56 HER2 overexpression 56 FISH fluorescence 56 miRNA molecules 56 gene expression 56 BAC clones 56 promoter methylation 56 amplicon 56 ChIP seq 56 breast cancer subtypes 56 molecular biomarkers 56 TaqMan 56 ependymomas 56 gastric carcinoma 56 Affymetrix GeneChip ® 56 HRCT 56 immunostaining 56 MSH2 56 quantitative trait loci 55 KRAS oncogene 55 Rosetta Genomics microRNA 55 miRview ™ mets 55 thyroid carcinoma 55 microarrays 55 splice junctions 55 CytoSure 55 haematopoietic 55 gene expression microarrays 55 metabolomic 55 PCR assay 55 N glycan 55 methylated DNA 55 genetic loci 55 protein biomarker discovery 55 VKORC1 55 prostate carcinoma 55 quantitative reverse transcriptase 55 KRAS BRAF 55 eTag assays 55 cell lysate 55 proteomic analyzes 55 proteomic analysis 55 DIGE 55 genotyping gene expression 55 clinicopathologic 55 CYP#D# gene 55 FFPE tissues 55 metabolomic profiles 55 Phenotypic 55 SNP Array #.# 55 #p# [003] 55 Illumina genotyping 55 miRNAs 55 cytological 55 cytogenetic abnormalities 55 epitope mapping 55 FLT3 55 whole genome genotyping 55 LHRH receptor positive 55 Immunohistochemistry 55 nucleic acid sequence 55 ALK mutations 55 mutated K ras 55 resequencing 55 distant metastasis 55 metabolite identification 55 breast carcinoma 55 Oncotype 55 microRNA profiling 55 T#I [002] 55 Li Fraumeni 55 microdeletion 55 nucleotide variations 55 differentially expressed genes 55 stratify patients 55 HSCT 55 syngeneic 55 histologies 55 transcriptional profiling 55 adverse cytogenetics 55 putative biomarkers 55 mesenchymal 55 COLD PCR 55 miRview ® 55 essential thrombocythemia 55 karyotype 55 array comparative genomic 55 NSCLC tumors 55 ADRB2 55 atypical hyperplasia 55 KEGG 55 targeted resequencing 55 Histologic 55 Comparative Genomic Hybridization 55 AvalonRx R 55 transcriptome 55 non coding RNA 55 miRview ™ squamous 55 shRNA libraries 54 multivariate Cox 54 biomarker identification 54 prognostic biomarker 54 transcriptome profiling 54 Corus CAD 54 genomic sequencing 54 fetal aneuploidy 54 chromosome #q#.# [001] 54 RNA amplification 54 mutational analysis 54 whole genome sequencing 54 molecular abnormalities 54 immunofluorescent 54 #S rRNA 54 Genotyping 54 DNA methyltransferases 54 retrospective cohort 54 haplotypes 54 chromosomal regions 54 chromosomal anomalies 54 EGFR TKIs 54 susceptibility loci 54 cDNA libraries 54 karyotypes 54 Infinium assay 54 microsatellite instability 54 ependymoma 54 oligo 54 nucleic acid amplification 54 histopathology 54 HER2 expression 54 somatic mutation 54 tissue microarray 54 hamartomas 54 flow cytometric 54 APTIMA HPV 54 K RAS 54 oligonucleotide microarrays 54 HLA genotyping 54 tumor histology 54 hepatocellular carcinomas 54 hematopoietic cancers 54 haplotype map 54 histological subtype 54 ERCC1 54 Syllego system 54 high throughput genotyping 54 aneuploidies 54 genomic DNA 54 mRNA expression 54 Sanger Sequencing 54 antisense oligonucleotides 54 SNPs 54 nonmetastatic 54 RNA seq 54 #p#.# [002] 54 OnDose TM 54 genomewide association studies 54 HERmark assay 54 genotyped 54 TMPRSS2 ERG fusion 54 multiplex assays 54 Dr. Victor Velculescu 54 Hakonarson 54 HER2 gene 54 methylation patterns 54 antibody reagents 54 MassARRAY platform 54 gene expression microarray 54 chromosome #p# [002] 54 VerifyNow P#Y# 54 GSTP1 54 PCR RFLP 54 haplotyping 54 TOP2A 54 chromosomal abnormalities 54 GeneSightRx 54 multiplex assay 54 SNP rs# [001] 54 genotyping sequencing 54 PCR assays 54 immunohistochemical analysis 54 exon arrays 54 ultrastructural 54 Genotypic 54 primate genomes 54 paraffin embedded tissue 54 Microarray analysis 54 biochemical assays 54 Epigenomics proprietary 54 genomic loci 54 accurate quantitation 54 lentiviral 54 epithelial ovarian cancer 54 PROLARIS 54 Y STR 54 PCR amplification 54 medulloblastomas 54 cytokeratin 54 Array CGH 54 differentiate squamous 54 Immunohistochemistry IHC 54 microsatellite markers 54 CLIA laboratory 54 DNA microarray 54 chromosome abnormalities 54 immunoglobulin genes 54 lymph node metastasis 54 CDKN2A 54 LungExpress Dx TM 54 microdroplet PCR 53 HAAH 53 5q deletion 53 AlloMap 53 T1a 53 allogeneic transplant 53 metabonomics 53 tandem mass spectrometry 53 CIN2 + 53 WT1 53 situ hybridization FISH 53 chemosensitivity 53 biomarker discovery 53 ChIP 53 DNA methylation patterns 53 VNTR 53 DNA methylation biomarkers 53 genetic biomarkers 53 MicroRNA 53 colorectal cancer CRC 53 EGFR gene 53 mutational 53 sequence homology 53 kidney urologic 53 prostate cancer CaP 53 FGFR3 53 epigenomic 53 oligonucleotide ligation 53 exomes 53 EUS FNA 53 protein biomarker 53 CLIA certified laboratory 53 5q 53 genetic markers 53 linkage disequilibrium 53 causal variants 53 Histological 53 UGT#A# 53 sensitivity specificity 53 JMML 53 CGH CNV 53 proteomic biomarkers 53 mucinous 53 missense mutations 53 genotyping arrays 53 Oncotype DX colon cancer 53 biospecimen 53 chromosome #p# [001] 53 genomic variation 53 molecular markers 53 prognostic indicators 53 urine cytology 53 molecular subtypes 53 polymorphisms 53 indel 53 NPM1 mutation 53 miRNA sequences 53 reaction RT PCR 53 PTEN gene 53 proteome 53 biopsied tissue 53 Multivariate logistic regression 53 multivariate analyzes 53 kinase assay 53 activating mutation 53 TLE3 53 cytologic 53 cytogenic 53 BRCA1 BRCA2 53 FDG-PET/CT 53 quantitation 53 PGRN 53 urothelial carcinoma 53 tumorigenicity 53 SurePrint 53 VeraCode 53 segmental duplications 53 CALGB 53 flow cytometers 53 comparative genomic 53 fetal echocardiography 53 transcriptional regulation 53 mitochondrial genome 53 HPV genotyping 53 indels 53 intergenic regions 53 biorepositories 53 underwent resection 53 ThinPrep Pap Test 53 epigenetic markers 53 urothelial bladder cancer 53 metabolomic profiling 53 mass spectrometric 53 HLA DQ2 53 allogeneic HSCT 53 RNA extraction 53 siRNA transfection 53 Estrogen Receptor 53 amplicons 53 diagnostic biomarker 53 genomic biomarker 53 histology 53 Her2/neu 53 oligonucleotide arrays 53 Haptoglobin 53 extracolonic 53 IMPROVE HF 53 CDH1 53 Figure 2C 53 renal tumors 53 NPM1 gene 53 SUVmax 53 lymphadenectomy 53 functional annotation 53 ELISpot 53 underwent surgical resection 53 molecular assays 53 ribosomal RNA rRNA 53 aneuploid 53 proton MR spectroscopy 53 EGFR mutation status 53 gastric carcinomas 53 cis regulatory 53 Alu elements 53 NMIBC 53 P. patens 53 PCa 53 axillary lymph node 53 bacterial genomes 52 proteomes 52 castrate resistant 52 cDNA microarray 52 APOE e4 52 shotgun sequencing 52 body louse genome 52 BRAF mutations 52 CRISPR 52 SLNB 52 substrate specificity 52 gene locus 52 lung adenocarcinoma 52 neuroblastomas 52 SVMs 52 causative mutations 52 STK# [002] 52 genomics transcriptomics 52 NNRTI resistance 52 pDCs 52 completely resected 52 thrombophilia 52 Xanafide 52 tumor specific antigen 52 tubulin inhibitor 52 Clusterin 52 SWOG 52 ADME Tox 52 F FDG PET 52 biospecimens 52 SLN biopsy 52 M. genitalium 52 clinico pathological 52 circulating endothelial cells 52 genomic epigenomic 52 PTPN# 52 paraffin embedded 52 QTL mapping 52 myelofibrosis polycythemia vera 52 micro RNA 52 operable breast cancer 52 malignant nodules 52 anti CD# antibodies 52 immunofluorescence 52 predictive biomarkers 52 micrometastasis 52 lymphoid tumors 52 peripheral blood mononuclear 52 situ hybridisation 52 inferential statistics 52 Drosha 52 BAN #/#/# [001] 52 DNA methylation profiling 52 exons 52 protein electrophoresis 52 cellularity 52 SureSelect 52 aneuploidy 52 histocompatibility 52 platelet reactivity 52 epigenomics 52 scintigraphic 52 high throughput sequencing 52 Sequencing Systems 52 PreGen Plus 52 hematologic malignancy 52 genetic variants associated 52 bioanalysis 52 ParAllele 52 diagnostic prognostic 52 CINtec R 52 Single Nucleotide Polymorphism 52 genetic 52 C#Y 52 intraobserver 52 differentially expressed proteins 52 epigenetic therapies 52 vitro assay 52 CGEMS 52 CISH 52 dinucleotide 52 RQ PCR 52 PALB2 52 chromosomal 52 VeriStrat 52 miRNA assays 52 CYP#C# [002] 52 tumor subtypes 52 thyroglobulin 52 Elucidator system 52 miRBase 52 proteomics 52 myeloproliferative disorders 52 #q# [001] 52 KRAS 52 sporadic ALS 52 NPM1 mutations 52 sequenced genomes 52 gene rearrangements 52 inbred strains 52 aneuploidy screening 52 CT angiograms 52 proteomic profiling 52 perilipin 52 nodal metastasis 52 allele frequencies 52 #q#.# [002] 52 PD2i ® 52 cisplatin resistant 52 prognostic marker 52 Meta analyzes 52 neoadjuvant 52 histologic subtypes 52 FGFR2 52 deCODE BreastCancer TM 52 core needle biopsy 52 troponins 52 ELISPOT 52 metaplasia 52 #q# [002] 52 HIV tropism 52 bioinformatic 52 flavopiridol 52 Human Leukocyte Antigen 52 capillary electrophoresis 52 Western blot 52 MammaPrint ® 52 Affymetrix GeneChip 52 chromosomal deletions 52 neoplasms 52 Formalin Fixed Paraffin Embedded 52 Affymetrix SNP Array 52 UTRs 52 #p#.# [001] 52 ResponseDX Lung ™ 52 heterologous expression 52 FFPE tissue 52 perfusion imaging 52 mammalian genomes 52 bladder carcinoma 52 HERmark 52 malignant phenotype 52 TaqMan assays 52 ErbB2 positive 52 Circulating Tumor Cells 52 comparative genomic analysis 52 Multiple logistic regression 52 mtDNA mutations 52 prognostic variables 52 PCR amplified 52 perfusion MRI 52 nucleotide substitutions 52 cTnI 52 QPCR 52 qPCR 52 MALDI MS 52 whole exome sequencing 52 hypomethylation 52 AttoSense 52 transrectal ultrasound guided 52 pancreatic cysts 52 genetic abnormalities 52 EGFR tyrosine kinase inhibitors 52 LRAT 52 biochemical recurrence 52 chromosomal rearrangements 52 K#R [002] 52 adjuvant trastuzumab 52 lymphoid cells 52 miRview mets 52 polymerase chain reactions 52 transplantation HSCT 52 stratifying patients 52 Zevalin consolidation 52 PCR primers 52 chromosomal aberrations 52 genotypes 52 oligonucleotide probes 52 System IPSS 52 lymph node metastases 52 Immunohistochemical staining 52 TTR gene 52 miRview squamous 52 MTHFR 52 KRAS gene 52 RRM1 51 miRview TM mets 51 microRNA miRNA 51 chromosomal mutations 51 extracolonic findings 51 ADME 51 methylation 51 bone marrow mesenchymal stem 51 coding genes 51 isotype 51 noninvasive imaging 51 microRNAs miRNAs 51 BeadChip 51 HLA DQ 51 autologous SCT 51 reagent kit 51 loci 51 HAR1 51 Serological 51 chromosome #q 51 taxane therapy 51 exon 51 radical nephrectomy 51 hematological relapse 51 clefting 51 MSn 51 thyroid carcinomas 51 MGd 51 molecular diagnostic assays 51 galectin 3 51 mTOR inhibitors 51 HER2 51 glycan 51 malignant transformation 51 normal karyotype 51 SNP Genotyping 51 protein kinases 51 haematologic 51 EGFR expression 51 DHPLC 51 X. tropicalis 51 nodal metastases 51 germline mutations 51 miRNA biomarkers 51 2D electrophoresis 51 adjuvant therapies 51 lymphovascular invasion 51 mutant alleles 51 PET CT scans 51 dbSNP 51 ZFN 51 uncharacterized genes 51 susceptibility genes 51 protein quantitation 51 #T# L1 51 diagnostic 51 multimodality imaging 51 transcriptomics 51 LungExpress Dx 51 prognostic factors 51 BRCA2 carriers 51 malignant lesions 51 causative gene 51 RNA Seq 51 Microarray 51 SNP rs# [002] 51 Cervista HPV HR 51 carcinoid 51 genomic rearrangements 51 maternal serum 51 toxicogenomics 51 lymph node involvement 51 PK PD 51 pretransplant 51 baseline LDH 51 FGFR1 51 pathologic examination 51 amaZon 51 transgenic rats 51 transgene expression 51 histologic subtype 51 hyper IgE syndrome 51 #F FDG PET 51 ribonucleic acid RNA 51 oligonucleotide microarray 51 Transcriptome 51 ABL1 51 noncoding RNAs 51 transgenic mouse models 51 cytoreductive nephrectomy 51 FUS1 51 generalized vitiligo 51 genotyping assay 51 dysbindin 51 activating mutations 51 Agilent microarrays 51 cytotoxic therapies 51 ImmuKnow 51 biomarkers 51 beta globin gene 51 Jhdm2a 51 multiparametric 51 unfavorable cytogenetics 51 KRAS mutation status 51 Cervista 51 automated microscopy 51 pluripotent embryonic 51 adenocarcinomas 51 neoplastic 51 rEEG 51 ResponseDX Lung TM 51 peritoneal carcinomatosis 51 multi analyte 51 FFPE samples 51 RT PCR 51 phase IIb clinical 51 H#K#me# 51 convergent validity 51 probe amplification MLPA 51 genomic transcriptomic 51 Prox1 51 Tr DNA 51 microbial genome 51 genetic polymorphisms 51 HIF PH inhibitors 51 human leukocyte antigens 51 MGMT gene 51 vitro ADME 51 PGxPredict tests 51 phenotypic traits 51 HLA antigens 51 variant allele 51 prognostic significance 51 guaiac 51 NGAL 51 serous ovarian cancer 51 xenograft models 51 DNA rearrangements 51 miRs 51 monogenic 51 MLL2 51 APOL1 51 Illumina Genome Analyzer 51 International HapMap Project 51 hyperoxaluria 51 Renal Cell Carcinoma RCC 51 KRAS status 51 phenotypic 51 protein microarrays 51 chemometrics 51 chromosomal rearrangement 51 BioMAP 51 HNPCC 51 HLA markers 51 ECOG 51 endoglin 51 exome capture 51 pancreatic lung 51 ABCB1 51 Histopathological 51 acid phosphatase PAP 51 Fourier transform infrared 51 hematopoietic cell 51 haplotype 51 HMGCR 51 heterozygosity 51 comparative genomics 51 Exome 51 neoadjuvant treatment 51 PICALM 51 iTRAQ 51 GPC5 51 metabolite profiling 51 prostatic adenocarcinoma 51 gene methylation 51 deacetylase 51 FMR1 51 gene variants 51 CHO K1 51 sentinel lymph node biopsy 51 D Dimer 51 rs# [002] 51 neoadjuvant therapy 51 ultrasonographic 51 complete cytogenetic response 51 conditional logistic regression 51 protein isoforms 51 morphological 51 Microarrays 51 imaging modality 51 variant rs# 51 LVNC 51 GPx 51 causative mutation 51 NFKBIA 51 cDNA 51 genomic biomarkers 51 Mammostrat 51 OGG1 51 granulocyte 51 Mass Spectrometry MS 51 oncologic outcomes 51 orthologous 51 reagent kits 51 NEDD9 51 heterozygotes 51 quantitative polymerase chain 51 microRNA 51 Mass spectrometry 51 microRNA molecules 51 squamous 51 ribosomal proteins 51 morphometrics 51 idiopathic myelofibrosis 51 shRNAs 51 xTAG Cystic Fibrosis 51 CC genotype 51 pT3 51 insertions deletions 51 blood serum biomarkers 51 ovarian carcinoma 51 biomarker assay 51 Septin9 51 DNA methylation biomarker 51 specific CD8 + 51 histopathologic findings 51 neoplastic cells 51 advanced neoplasia 51 TYMS 51 functional genomics 51 ALN TTR 51 risk stratification 51 ENMD # 51 specific antigen PSA 51 genome rearrangements 51 orthologs 51 HER2 positive cancers 51 immunochemistry 51 interobserver 51 oligos 51 beta1 integrin 51 SmartChip System 51 Mesenchymal 51 Mutational 51 electrophysiologic 51 Imaging BSGI 51 carboxyl terminal 51 kinase inhibition 51 comparative genomic hybridization CGH 51 IGF IR 51 prognostic 51 preanalytical 51 mRNA molecules 51 pharmacokinetic PK 51 Western Blotting 51 metabolomics 50 ELISA assays 50 Circulating tumor cells 50 ALK gene 50 univariate 50 kidney allograft 50 #q#.# deletion syndrome 50 rs# [003] 50 radiochemotherapy 50 comparative genomic hybridization aCGH 50 FDG PET scans 50 NF1 gene 50 UsiRNAs 50 anti JCV antibodies 50 HBsAg 50 EoE 50 eukaryotic genomes 50 phenotypic expression 50 GenPath 50 malaria parasite genome 50 Affymetrix microarray technology 50 colorectal liver metastases 50 histologic diagnosis 50 CYP#C# [001] 50 histopathologic examination 50 molecular cytogenetics 50 independent prognostic marker 50 fetal chromosomal abnormalities 50 Next Generation Sequencing 50 colorectal tumor 50 pancreatic islet cell 50 viral tropism 50 BCL#A 50 hENT1 50 SILAC 50 histone modification 50 antisense inhibitors 50 quasispecies 50 atherosclerosis regression 50 dedifferentiation 50 DCE MRI 50 genotype 50 pCR 50 Quantitative PCR 50 prospectively defined 50 miRNA expression profiles 50 pharmacogenomic 50 CT Colonography 50 imprinted genes 50 lung adenocarcinomas 50 serum biomarkers 50 PSADT 50 Illumina NASDAQ ILMN 50 chromosome #q# [002] 50 maternally inherited 50 progesterone receptor PR 50 nucleated cells 50 Sentinel Lymph Node Biopsy 50 core needle biopsies 50 HIV HCV coinfected 50 detecting colorectal cancer 50 osteosarcomas 50 PSA nadir 50 HeliScope Sequencer 50 nonalcoholic steatohepatitis NASH 50 FDG PET 50 rs# [001] 50 diagnostic assays 50 CLIA certified 50 Her2 gene 50 Secondary efficacy endpoints 50 miRNA expression patterns 50 kinome 50 delta isoform 50 EpCAM expression 50 buffy coat 50 AviaraDx 50 mutated genes 50 allogeneic SCT 50 Subgroup analysis 50 succinate dehydrogenase 50 chromosome #p#.# 50 Copy Number 50 vivo potency 50 phenotype 50 plain radiographs

Back to home page